antique boat parts Antique Boat Motor Parts Antique Boat Parts Logo

Welcome to
antique-boat-motor-parts.com

National Resource Center
antique boat parts Antique Boat Motor Parts Antique Boat Parts division
301 Union Ave
Altoona, PA 16602

Your source for information about antique boat parts Antique Boat Motor Parts Antique Boat Parts

People who visit antique-boat-motor-parts.com are also interested in: antique, antique boat parts, boat, boats, antique boat, wood, runabout, mahogany, old, woodboat and antique.



antique boat parts
Antique Boat Motor Parts Antique Boat Parts
Related Topics:
antique
antique boat parts
boat
boats
antique boat
wood
runabout
mahogany
old
woodboat
woodenboat
Chris Craft
runabouts
Century
classic
wooden
Lou Rauh
outboard
wooden boats
classic Chris Craft parts
classic boats
antique wood Chris-Craft
mahogany boats
for sale
classic Chris-Craft boats
boat parts
Hackercraft
antique Chris-Craft
antique chris craft
antique boats
Gar Wood
marine
marina
speedboats
restoration
classic boat
wood boats
buyer
broker
seller





Antique Boat Motor Parts Antique Boat Parts antique boat parts

.

Antique Boat Motor Parts Antique Boat Parts antique boat parts Information

THE CANCER PILL

Dr. Brian Druker of Oregon Health Sciences University was searching for a compound that could block the enzyme that caused chronic myelogenous leukemia or CML for short. He recently stabilized a compound he had noticed to suppress the enzyme, that compound, STI 571, was recently being run through clinical trials to verify its action. He has been working at Oregon Health Sciences University on the pill, but the distribution and trials of the drugs are being run through Novartis Pharmaceuticals. The outcome of this revolutionary cancer treatment could help many people currently suffering from this condition if its trials prove it completely safe. So far in the clinical trials it has had a one hundred percent success rate curing thirty-one out of thirty-one patients so far tested. The Leukemia Society of America, the National Cancer Institute, Novartis Pharmaceuticals, and the Oregon Cancer Center fund Dr. Druker’s research and studies. So far the research has only been tested on CML leukemia, but there is doubt it will work on other forms because it was specifically formulated for the suppression of the enzyme responsible for CML leukemia and its specific chromosome, the Philadelphia chromosome. Out of all the forms of leukemia CML accounts for about 1/7 of the cases only affecting about one to two people per one hundred thousand, most above the age of 50. It causes an enormous increase in the white blood cell count, sometimes as great as twelve fold or from the average 10,000 to 120,000. In most cases you die about one to three years after diagnosis.




Site Links --- Google Sitemap --- Yahoo Sitemap --- Human Sitemap --- Related Links --- States

This site is designed and maintained by Links are Blue and Get 50+ Free Text Links